Metraipolis › archive › dc_ea56be5e103b

Tracking COVID-19 Severity and Progression Through Amines and Lipid Mediators — Europe PMC PMID:42422977

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42422977
DOI
10.1002/jmv.71030
License (as archived)
solo-consultazione
Archived
2026-10-15T18:11:34.004Z
SHA-256 of the archived text
733e95e694f3c68321a9f4fdb666f1583b5107be89cb28898087202725e2d40d
Stable URL of this page
https://metraipolis.com/documento/dc_ea56be5e103b

How to cite

Tracking COVID-19 Severity and Progression Through Amines and Lipid Mediators — Europe PMC PMID:42422977 — Europe PMC (en), https://europepmc.org/article/MED/42422977 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ea56be5e103b (Metraipolis archive dc_ea56be5e103b, sha256 733e95e694f3c68321a9f4fdb666f1583b5107be89cb28898087202725e2d40d)
BibTeX
@misc{dcea56be5e103b,
  title = {Tracking COVID-19 Severity and Progression Through Amines and Lipid Mediators — Europe PMC PMID:42422977},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42422977},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ea56be5e103b; sha256 733e95e694f3c68321a9f4fdb666f1583b5107be89cb28898087202725e2d40d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42422977. Agents can read the archived copy with the MCP tool read_document.